Navigation Links
Codexis Names Vice President, Intellectual Property
Date:9/23/2008

REDWOOD CITY, Calif., Sept. 23 /PRNewswire/ -- Codexis, Inc., today announced the appointment of Lynn Marcus-Wyner, Ph.D., as Vice President, Intellectual Property. She will be responsible for managing the company's intellectual property strategy, activities, and patent portfolio and will report to Douglas Sheehy, Vice President, General Counsel and Secretary.

Dr. Marcus-Wyner joins Codexis from Danisco A/S, where as Senior Director, Intellectual Assets US, she managed the United States patent department of the Genencor division. Previously, she was in private intellectual property law practice representing clients, including Genencor International, Inc., and Novartis Corporation, and held a legal patent management position at Sandoz Agro Inc. Dr. Marcus-Wyner was also a Patent Attorney at Zeneca Inc. (formerly ICI Americas Inc). Dr. Marcus-Wyner has a J.D. from the University of the Pacific, McGeorge School of Law and a Ph.D. in plant physiology from the University of California, Davis. Prior to law school, Dr. Marcus-Wyner was an Assistant Professor in the Plant and Soil Science Department at the University of Massachusetts, Amherst.

"Building and protecting our intellectual property portfolio is a key success factor for Codexis," Mr. Sheehy said. "Dr. Marcus-Wyner has broad experience counseling life science and bioindustrial companies on intellectual property law matters, and brings a proven track record in managing this important function in our industry," Mr. Sheehy said. "We are very pleased to add her to the Codexis legal team."

Codexis is a leading developer of proprietary biocatalysts that the company believes have the potential to revolutionize chemistry-based manufacturing processes across a variety of industries. The company has used its technology platform to enable biocatalyst-based commercial-scale drug manufacturing processes and delivered biocatalysts and drug products to some of the world's leading pharmaceutical companies. Codexis has a funded research collaboration in the biofuels market, and the company is pursuing funded collaborations in several other bioindustrial markets, including carbon management, water treatment and chemicals.
CONTACT: Lyn Christenson, lyn.christenson@codexis.com,

650-421-8144, or Justin Jackson, jjackson@burnsmc.com,

Burns McClellan, 212-213-0006


'/>"/>
SOURCE Codexis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Codexis, Arch Announce Expanded Collaboration
2. Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering
3. Codexis Names David Anton VP Bioindustrials R&D
4. Codexis Launches Codex(TM) MicroCyp Platform to Produce Drug Metabolites and Novel Lead Compounds
5. Rothwell, Wolf Elected to Codexis Board
6. Codexis Opens Singapore Laboratory
7. Bruce Pasternack Elected to Codexis Board
8. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
9. Codexis Appoints Singapore Laboratories Managing Director
10. Genstruct Names Louis Latino VP of Sales
11. Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... regulatory and technical consulting, provides a free webinar on Performing Quality ... 13, 2016 at 12pm CT at no charge. , Incomplete investigations are still ...
Breaking Biology Technology:
(Date:6/15/2016)... , June 15, 2016 ... report titled "Gesture Recognition Market by Application Market - Global Industry ... - 2024". According to the report, the  global gesture ... in 2015 and is estimated to grow at ... billion by 2024.  Increasing application of ...
(Date:6/2/2016)... , June 2, 2016 The Department ... has awarded the 44 million US Dollar project, for the ... Vehicle Plates including Personalization, Enrolment, and IT Infrastructure , ... in the production and implementation of Identity Management Solutions. Numerous ... however Decatur was selected for the ...
(Date:5/20/2016)... 2016  VoiceIt is excited to announce its ... By working together, VoiceIt and VoicePass will ... VoicePass take slightly different approaches to voice biometrics, ... and usability. ... partnership. "This marketing and technology partnership ...
Breaking Biology News(10 mins):